{name}
{subtitle}
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~7 mi. (Patchogue, New York, +127 more cities)
facility
North Shore Hematology Oncology Assoc. P.C. DBA NY Cancer and Blood Specialists
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~10 mi. (Bay Shore, New York, +825 more cities)
facility
South Shore University Hospital
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~10 mi. (Bay Shore, New York, +954 more cities)
facility
Northwell Health Imbert Cancer Center
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
city
~10 mi. (Bay Shore, New York, +638 more cities)
facility
Northwell Health Imbert Cancer Center
drug
bevacizumab, +3 more drugs
drug type
chemotherapy, +2 more types
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma
city
~10 mi. (Bay Shore, New York, +507 more cities)
facility
Northwell Health Imbert Cancer Center
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
city
~14 mi. (Commack, New York, +126 more cities)
facility
Research Site
biomarker
ER Positive, +2 more biomarkers